Trial Information
Study Evaluating the Interest of Cytology-molecular Tumor Markers Association for the Diagnostic Strategy in Adult Kidney Tumors
Inclusion Criteria:
- Clinical diagnosis of kidney tumor < 4 cm
- Cystic kidney tumor (Bosniak > IIF)
- Consent signed
Exclusion Criteria:
- Benign tumor confirmed
- Impossibility to do abdominal pelvic ultra-sound or abdominal thoracic scanner
- Contraindication for renal puncture
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Histologic diagnostic (tumor)
Outcome Time Frame:
after surgery or biopsy
Safety Issue:
No
Principal Investigator
Jacques TOSTAIN, PhD-MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
CHU de Saint-Etienne
Authority:
France: French Data Protection Authority
Study ID:
0501106
NCT ID:
NCT00491621
Start Date:
April 2007
Completion Date:
January 2015
Related Keywords:
- Kidney Neoplasms
- kidney
- tumor
- Molecular Markers
- Cytology
- Histology
- Cystic kidney tumor
- Neoplasms
- Kidney Neoplasms